nevirapine has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 3 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Radi, M | 1 |
Maga, G | 1 |
Alongi, M | 1 |
Angeli, L | 1 |
Samuele, A | 1 |
Zanoli, S | 1 |
Bellucci, L | 1 |
Tafi, A | 1 |
Casaluce, G | 1 |
Giorgi, G | 1 |
Armand-Ugon, M | 1 |
Gonzalez, E | 1 |
Esté, JA | 1 |
Baltzinger, M | 1 |
Bec, G | 1 |
Dumas, P | 1 |
Ennifar, E | 1 |
Botta, M | 1 |
Yan, ZH | 1 |
Wu, HQ | 1 |
Chen, WX | 1 |
Wu, Y | 1 |
Piao, HR | 1 |
He, QQ | 1 |
Chen, FE | 1 |
De Clercq, E | 2 |
Pannecouque, C | 2 |
Sang, Y | 1 |
Han, S | 1 |
Zhuang, C | 1 |
Chen, F | 1 |
3 other studies available for nevirapine and Precursor Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Discovery of chiral cyclopropyl dihydro-alkylthio-benzyl-oxopyrimidine (S-DABO) derivatives as potent HIV-1 reverse transcriptase inhibitors with high activity against clinically relevant mutants.
Topics: Cell Line, Tumor; Computer Simulation; Drug Design; Drug Resistance, Viral; HIV Reverse Transcriptas | 2009 |
Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Benzamides; Cell Survival; Cells, Cultured; Drug Design; HIV Reverse Transcriptase; | 2014 |
Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic Profiles.
Topics: Administration, Oral; Animals; Anti-HIV Agents; Apoptosis; Drug Design; Female; HIV Infections; HIV- | 2019 |